can tirzepatide be compounded GLP-1/GIP Program Addressing the Weight Loss Injectable

After the actor revealed severe gastrointestinal symptoms following a low-dose GLP-1 injection, experts explain how common serious side effects are, who is at risk, and when patients should seek urgent medical care.

Craig Primack, Hims & Hers SVP of Weight Management, joins 'Closing Bell Overtime' to talk the company offering a GLP-1 drug through its platform.

Weight Management Tirzepatide is approved for chronic weight management in: Adults with obesity (BMI 30) Adults with overweight (BMI 27) with weight-related comorbidities[5][6][1] It reduces appetite, enhances satiety, and prolongs fullness[5]

Fragmented care, such as receiving prescriptions from specialists without informing primary care providers, can further disrupt continuity in therapy

Never share your pen with others, even if the needle is changed

Professor Giles Yeo joins this Journal Club session to discuss a recently published clinical trial paper exploring the effects of the weight loss drug, semaglutide.